- Home
- ALMS vs KELYB Comparison
ALMS vs KELYB Comparison
Compare ALMS & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- KELYB
- Stock Information
- Founded
- ALMS 2021
- KELYB 1946
- Country
- ALMS United States
- KELYB United States
- Employees
- ALMS N/A
- KELYB N/A
- Industry
- ALMS
- KELYB Professional Services
- Sector
- ALMS
- KELYB Consumer Discretionary
- Exchange
- ALMS NYSE
- KELYB Nasdaq
- Market Cap
- ALMS 402.6M
- KELYB 426.3M
- IPO Year
- ALMS 2024
- KELYB N/A
- Fundamental
- Price
- ALMS $4.13
- KELYB $12.50
- Analyst Decision
- ALMS Strong Buy
- KELYB
- Analyst Count
- ALMS 6
- KELYB 0
- Target Price
- ALMS $19.80
- KELYB N/A
- AVG Volume (30 Days)
- ALMS 686.1K
- KELYB 786.0
- Earning Date
- ALMS 08-12-2025
- KELYB 08-07-2025
- Dividend Yield
- ALMS N/A
- KELYB 2.40%
- EPS Growth
- ALMS N/A
- KELYB N/A
- EPS
- ALMS N/A
- KELYB N/A
- Revenue
- ALMS $17,389,000.00
- KELYB $4,451,600,000.00
- Revenue This Year
- ALMS N/A
- KELYB $8.06
- Revenue Next Year
- ALMS N/A
- KELYB $4.08
- P/E Ratio
- ALMS N/A
- KELYB N/A
- Revenue Growth
- ALMS N/A
- KELYB N/A
- 52 Week Low
- ALMS $2.76
- KELYB $11.04
- 52 Week High
- ALMS $13.11
- KELYB $22.16
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- KELYB 49.98
- Support Level
- ALMS N/A
- KELYB $12.94
- Resistance Level
- ALMS N/A
- KELYB $13.16
- Average True Range (ATR)
- ALMS 0.00
- KELYB 0.23
- MACD
- ALMS 0.00
- KELYB -0.01
- Stochastic Oscillator
- ALMS 0.00
- KELYB 28.40
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.